Kwang Soo Cha
Overview
Explore the profile of Kwang Soo Cha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
905
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oh J, Kim J, Kim J, Lee H, Lee S, Choe J, et al.
J Korean Med Sci
. 2024 Dec;
39(47):e294.
PMID: 39662498
Background: The optimal duration and net clinical benefit of dual antiplatelet therapy (DAPT) after transcatheter aortic valve replacement (TAVR) have not been elucidated in real-world situations. Methods: Using nationwide claims...
2.
Lee S, Kim R, Seo C, Kim M, Lee H, Kim H, et al.
PLoS One
. 2024 Jun;
19(6):e0304273.
PMID: 38843207
Background: High-risk non-ST-elevation myocardial infarction (NSTEMI) patients' optimal timing for percutaneous coronary intervention (PCI) is debated despite the recommendation for early invasive revascularization. This study aimed to compare outcomes of...
3.
Kwon Y, Kim N, Kim C, Kim D, Shin H, Jung M, et al.
PLoS One
. 2024 Jun;
19(6):e0304843.
PMID: 38838047
Imaging modalities for percutaneous coronary intervention (PCI), such as intravascular ultrasound (IVUS) or optical coherence tomography (OCT), have increased in the current PCI era. However, their clinical benefits in acute...
4.
Kim M, Kang D, Kim M, Choe J, Lee S, Ahn J, et al.
J Am Med Inform Assoc
. 2024 May;
31(7):1540-1550.
PMID: 38804963
Objective: Predicting mortality after acute myocardial infarction (AMI) is crucial for timely prescription and treatment of AMI patients, but there are no appropriate AI systems for clinicians. Our primary goal...
5.
Lee J, Youn Y, Jeon H, Lee J, Ahn S, Yoon J, et al.
J Korean Med Sci
. 2024 Mar;
39(10):e111.
PMID: 38501187
Background: The benefits of transradial access (TRA) over transfemoral access (TFA) for bifurcation percutaneous coronary intervention (PCI) are uncertain because of the limited availability of device selection. This study aimed...
6.
Park S, Kim D, Lee K, Park M, Chang K, Jeong M, et al.
Sci Rep
. 2024 Mar;
14(1):365.
PMID: 38429290
Body mass index (BMI), as an important risk factor related to metabolic disease. However, in some studies higher BMI was emphasized as a beneficial factor in the clinical course of...
7.
Yang S, Kang J, Park K, Hur S, Lee N, Hwang D, et al.
J Am Coll Cardiol
. 2023 Oct;
82(16):1565-1578.
PMID: 37821166
Background: Clopidogrel was superior to aspirin monotherapy in secondary prevention after percutaneous coronary intervention (PCI). Objectives: The purpose of this study was to evaluate the benefits of clopidogrel across high-risk...
8.
Kim B, Cha K, Cho W, Kim E, Choi S, Kim M, et al.
J Cardiovasc Pharmacol Ther
. 2023 Oct;
28:10742484231205204.
PMID: 37814541
Introduction: This study evaluated the efficacy and safety of a single-pill triple-combination of olmesartan/amlodipine/rosuvastatin (Olme/Amlo/Rosu) in comparison with a single-pill dual-combination of olmesartan/amlodipine (Olme/Amlo) in hypertensive patients with low-to-moderate cardiovascular...
9.
Cho E, Kim M, Kim Y, Chang K, Choi D, Kang W, et al.
J Clin Hypertens (Greenwich)
. 2023 Aug;
25(9):817-827.
PMID: 37614053
The authors evaluated the efficacy, safety, and characteristics of patients who respond well to standard dose triple combination therapy including chlorthalidone 25 mg with telmisartan 80 mg plus amlodipine 5 ...
10.
Cho K, Shin M, Kim M, Sim D, Hong Y, Kim J, et al.
J Am Heart Assoc
. 2023 Jun;
12(13):e029728.
PMID: 37345749
Background Data on the incidence, relevant patient factors, and clinical outcomes of the misdiagnosis of ST-segment-elevation myocardial infarction (STEMI) in the modern era of percutaneous coronary intervention are limited. Methods...